| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Benzamides | 100 | + | |
2 | Pyrimidines | 93 | + | |
3 | Piperazines | 81 | + | |
4 | Mitobronitol | 74 | + | |
5 | Fusion Proteins, bcr-abl | 62 | + | |
6 | Cytarabine | 39 | + | |
7 | Protein-Tyrosine Kinases | 37 | + | |
8 | Organic Cation Transporter 1 | 37 | + | |
9 | Busulfan | 30 | + | |
10 | Thiazoles | 28 | + | |
11 | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 21 | + | |
12 | Interferon-alpha | 19 | + | |
13 | Daunorubicin | 16 | + | |
14 | fms-Like Tyrosine Kinase 3 | 12 | + | |
15 | Idarubicin | 12 | + | |
16 | Harringtonines | 11 | + | |
17 | Sialic Acid Binding Ig-like Lectin 3 | 10 | + | |
18 | Hydroxyurea | 9 | + | |
19 | Tretinoin | 9 | + | |
20 | Neoplasm Proteins | 9 | + | |
21 | Oncogene Proteins, Fusion | 9 | + | |
22 | Myeloid-Lymphoid Leukemia Protein | 8 | + | |
23 | Aminoglycosides | 8 | + | |
24 | RNA, Neoplasm | 7 | + | |
25 | Leukemia Inhibitory Factor | 7 | + | |
26 | Proto-Oncogene Proteins c-bcr | 7 | + | |
27 | Azacitidine | 7 | + | |
28 | Core Binding Factor Alpha 2 Subunit | 7 | + | |
29 | Arabinonucleosides | 7 | + | |
30 | Proto-Oncogene Proteins c-abl | 7 | + | |
31 | Vidarabine | 7 | + | |
32 | Arsenicals | 6 | + | |
33 | Asparaginase | 6 | + | |
34 | Arabinofuranosylcytosine Triphosphate | 6 | + | |
35 | Cladribine | 6 | + | |
36 | DNA, Neoplasm | 6 | + | |
37 | DNA Nucleotidylexotransferase | 6 | + | |
38 | Amsacrine | 6 | + | |
39 | Proto-Oncogene Proteins | 6 | + | |
40 | Thioguanine | 6 | + | |
41 | Vincristine | 5 | + | |
42 | DNA Nucleotidyltransferases | 5 | + | |
43 | RNA, Messenger | 5 | + | |
44 | Etoposide | 5 | + | |
45 | Interferon Type I | 5 | + | |
46 | 6-Mercaptopurine | 5 | + | |
47 | Oxides | 5 | + | |
48 | STAT5 Transcription Factor | 4 | + | |
49 | Granulocyte Colony-Stimulating Factor | 4 | + | |
50 | Core Binding Factors | 4 | + | |
51 | Arabinonucleotides | 4 | + | |
52 | Transcription Factors | 4 | + | |
53 | Nuclear Proteins | 4 | + | |
54 | Naphthacenes | 4 | + | |
55 | WT1 Proteins | 4 | + | |
56 | P-Glycoprotein | 4 | + | |
57 | Granulocyte-Macrophage Colony-Stimulating Factor | 4 | + | |
58 | Adenine Nucleotides | 4 | + | |
59 | Cytidine Monophosphate | 4 | + | |
60 | Antibodies, Monoclonal | 4 | + | |
61 | Oncogene Proteins | 4 | + | |
62 | Proto-Oncogene Proteins c-bcl-2 | 4 | + | |
63 | Recombinant Proteins | 4 | + | |
64 | DNA-Binding Proteins | 4 | + | |
65 | Farnesyltranstransferase | 4 | + | |
66 | Cyclophosphamide | 3 | + | |
67 | Methotrexate | 3 | + | |
68 | Myeloid Cell Leukemia Sequence 1 Protein | 3 | + | |
69 | Mitoxantrone | 3 | + | |
70 | Receptor Protein-Tyrosine Kinases | 3 | + | |
71 | Aclarubicin | 3 | + | |
72 | Doxorubicin | 3 | + | |
73 | Immunotoxins | 3 | + | |
74 | Phosphotransferases | 3 | + | |
75 | Receptors, Retinoic Acid | 3 | + | |
76 | src-Family Kinases | 3 | + | |
77 | Adaptor Proteins, Signal Transducing | 2 | + | |
78 | Dioxolanes | 2 | + | |
79 | Staurosporine | 2 | + | |
80 | Prednisone | 2 | + | |
81 | Chlorambucil | 2 | + | |
82 | Protein-Serine-Threonine Kinases | 2 | + | |
83 | Deoxycytidine Kinase | 2 | + | |
84 | DNA Primers | 2 | + | |
85 | Caspases | 2 | + | |
86 | Histones | 2 | + | |
87 | Core Binding Factor beta Subunit | 2 | + | |
88 | Hydroxamic Acids | 2 | + | |
89 | DNA Probes | 2 | + | |
90 | Proto-Oncogene Proteins c-kit | 2 | + | |
91 | Nucleotidyltransferases | 2 | + | |
92 | Rhodamine 123 | 2 | + | |
93 | Interleukin-2 | 2 | + | |
94 | Antigens, CD29 | 2 | + | |
95 | Deoxyadenosines | 2 | + | |
96 | Proto-Oncogene Proteins c-myc | 2 | + | |
97 | Protein Kinases | 2 | + | |
98 | Interleukin-3 Receptor alpha Subunit | 2 | + | |
99 | Antigens, CD45 | 2 | + | |
100 | Membrane Glycoproteins | 2 | + | |
101 | DNA (Cytosine-5-)-Methyltransferase | 2 | + | |
102 | Apoptosis Regulatory Proteins | 2 | + | |
103 | Thionucleotides | 2 | + | |
104 | Proto-Oncogene Proteins c-myb | 2 | + | |
105 | Octamer Transcription Factor-1 | 2 | + | |
106 | Aniline Compounds | 2 | + | |
107 | Interleukin-3 | 2 | + | |
108 | Receptors, Immunologic | 2 | + | |
109 | Deoxycytosine Nucleotides | 2 | + | |
110 | Interferons | 2 | + | |
111 | Antibodies, Neoplasm | 2 | + | |
112 | Folate Receptor 2 | 2 | + | |
113 | Phenylurea Compounds | 2 | + | |
114 | Receptors, Interleukin-3 | 2 | + | |
115 | Proto-Oncogene Proteins c-cbl | 2 | + | |
116 | Myeloblastin | 2 | + | |
117 | Trans-Activators | 2 | + | |
118 | Guanosine Triphosphate | 2 | + | |
119 | Receptors, Granulocyte Colony-Stimulating Factor | 2 | + | |
120 | Colony-Stimulating Factors | 2 | + | |
121 | Endoribonucleases | 2 | + | |
122 | Cytidine Deaminase | 2 | + | |
123 | Antibodies, Monoclonal, Humanized | 2 | + | |
124 | Vindesine | 2 | + | |
125 | Coformycin | 1 | + | |
126 | Protein Phosphatase 2 | 1 | + | |
127 | Natural Cytotoxicity Triggering Receptor 2 | 1 | + | |
128 | Immunoglobulin Heavy Chains | 1 | + | |
129 | DNA Modification Methylases | 1 | + | |
130 | Oligonucleotides, Antisense | 1 | + | |
131 | 5'-Nucleotidase | 1 | + | |
132 | Asparagine | 1 | + | |
133 | Naphthalimides | 1 | + | |
134 | Janus Kinase 2 | 1 | + | |
135 | GATA1 Transcription Factor | 1 | + | |
136 | 2-Chloroadenosine | 1 | + | |
137 | Proto-Oncogene Proteins c-akt | 1 | + | |
138 | Oligonucleotide Probes | 1 | + | |
139 | Pyridines | 1 | + | |
140 | Diphtheria Toxin | 1 | + | |
141 | Ribosome Inactivating Proteins, Type 1 | 1 | + | |
142 | Phosphotyrosine | 1 | + | |
143 | Antigens, CD38 | 1 | + | |
144 | Phosphoprotein Phosphatases | 1 | + | |
145 | Benzenesulfonates | 1 | + | |
146 | HSP90 Heat-Shock Proteins | 1 | + | |
147 | Recombinant Fusion Proteins | 1 | + | |
148 | DNA Polymerase II | 1 | + | |
149 | Receptors, KIR | 1 | + | |
150 | DNA, Complementary | 1 | + | |
151 | Deoxyribonuclease HpaII | 1 | + | |
152 | RNA, Small Interfering | 1 | + | |
153 | Receptors, Antigen, B-Cell | 1 | + | |
154 | Phosphoglycerate Kinase | 1 | + | |
155 | Purine Nucleosides | 1 | + | |
156 | Niacinamide | 1 | + | |
157 | Antigens, CD56 | 1 | + | |
158 | N-Glycosyl Hydrolases | 1 | + | |
159 | Tumor Suppressor Protein p53 | 1 | + | |
160 | Glycophorin | 1 | + | |
161 | Homeodomain Proteins | 1 | + | |
162 | Tumor Suppressor Proteins | 1 | + | |
163 | Nuclear Pore Complex Proteins | 1 | + | |
164 | TOR Serine-Threonine Kinases | 1 | + | |
165 | ZAP-70 Protein-Tyrosine Kinase | 1 | + | |
166 | Interferon-gamma | 1 | + | |
167 | Interferon Regulatory Factor-2 | 1 | + | |
168 | ATP-Binding Cassette Transporters | 1 | + | |
169 | Diterpenes | 1 | + | |
170 | Nitrogen Mustard Compounds | 1 | + | |
171 | Anthracyclines | 1 | + | |
172 | Multidrug Resistance-Associated Proteins | 1 | + | |
173 | Chromatin | 1 | + | |
174 | bcl-2-Associated X Protein | 1 | + | |
175 | Bryostatins | 1 | + | |
176 | Phosphatidylinositol 3-Kinases | 1 | + | |
177 | Indoles | 1 | + | |
178 | Caspase 3 | 1 | + | |
179 | DNA Topoisomerases, Type II | 1 | + | |
180 | Complement System Proteins | 1 | + | |
181 | Receptor, Notch1 | 1 | + | |
182 | Prednisolone | 1 | + | |
183 | Receptor, Macrophage Colony-Stimulating Factor | 1 | + | |
184 | Aminoacridines | 1 | + | |
185 | MicroRNAs | 1 | + | |
186 | Ricin | 1 | + | |
187 | Thymidine | 1 | + | |
188 | Reticulin | 1 | + | |
189 | IMP Dehydrogenase | 1 | + | |
190 | Amphotericin B | 1 | + | |
191 | Nocodazole | 1 | + | |
192 | 2',5'-Oligoadenylate Synthetase | 1 | + | |
193 | Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | + | |
194 | HSP40 Heat-Shock Proteins | 1 | + | |
195 | Ribonucleotide Reductases | 1 | + | |
196 | mRNA Cleavage and Polyadenylation Factors | 1 | + | |
197 | DNA | 1 | + | |
198 | Carrier Proteins | 1 | + | |
199 | Sialic Acid Binding Ig-like Lectin 2 | 1 | + | |
200 | Ribonucleosides | 1 | + | |
201 | Quinolones | 1 | + | |
202 | Antibodies, Monoclonal, Murine-Derived | 1 | + | |
203 | CCAAT-Enhancer-Binding Proteins | 1 | + | |
204 | Casein Kinase Ialpha | 1 | + | |
205 | Trimetrexate | 1 | + | |
206 | Cell Cycle Proteins | 1 | + | |
207 | Vault Ribonucleoprotein Particles | 1 | + | |
208 | Isocitrate Dehydrogenase | 1 | + | |
209 | Reactive Oxygen Species | 1 | + | |
210 | Imides | 1 | + | |
211 | Antigens, CD13 | 1 | + | |
212 | Phosphoproteins | 1 | + | |
213 | Aurora Kinases | 1 | + | |
214 | Interleukin Receptor Common gamma Subunit | 1 | + | |
215 | Annexin A5 | 1 | + | |
216 | Gene Products, tax | 1 | + | |
217 | Retinoids | 1 | + | |
218 | Taq Polymerase | 1 | + | |
219 | Cyclin D3 | 1 | + | |
220 | Antigens, CD44 | 1 | + | |
221 | Proto-Oncogene Proteins c-pim-1 | 1 | + | |
222 | RNA, Catalytic | 1 | + | |
223 | Aspartate-Ammonia Ligase | 1 | + | |
224 | Cytosine | 1 | + | |
225 | Interleukin-11 Receptor alpha Subunit | 1 | + | |
226 | Intracellular Signaling Peptides and Proteins | 1 | + | |
227 | Caspase 8 | 1 | + | |
228 | Thioinosine | 1 | + | |
229 | Immunoconjugates | 1 | + | |
230 | Mitogen-Activated Protein Kinase 3 | 1 | + | |
231 | Core Binding Factor alpha Subunits | 1 | + | |
232 | Cytokines | 1 | + | |
233 | bcl-X Protein | 1 | + | |
234 | Nucleosides | 1 | + | |
235 | Boronic Acids | 1 | + | |
236 | Lymphokines | 1 | + | |
237 | Benzoquinones | 1 | + | |
238 | Cytokine Receptor Common beta Subunit | 1 | + | |
239 | RNA-Binding Protein FUS | 1 | + | |
240 | Pyrazines | 1 | + | |
241 | Histone Deacetylases | 1 | + | |
242 | Receptors, Interleukin-11 | 1 | + | |
243 | Membrane Proteins | 1 | + | |
244 | Mitogen-Activated Protein Kinase 1 | 1 | + | |
245 | Proto-Oncogene Proteins c-jun | 1 | + | |
246 | CCAAT-Enhancer-Binding Protein-alpha | 1 | + | |
247 | Antigens, CD95 | 1 | + | |
248 | Nitrosourea Compounds | 1 | + | |
249 | Sialoglycoproteins | 1 | + | |
250 | Phospholipid Ethers | 1 | + | |
251 | Antigens, CD79 | 1 | + | |
252 | Mitoguazone | 1 | + | |
253 | Peptide Synthases | 1 | + | |
254 | Pyrimidine Nucleotides | 1 | + | |
255 | Equilibrative Nucleoside Transporter 1 | 1 | + | |
256 | Histone-Lysine N-Methyltransferase | 1 | + | |
257 | Plant Proteins | 1 | + | |
258 | Triazoles | 1 | + | |
259 | Antigens, CD47 | 1 | + | |
260 | Ataxia Telangiectasia Mutated Proteins | 1 | + | |
261 | Proto-Oncogene Proteins c-raf | 1 | + | |
262 | Teniposide | 1 | + | |
263 | Pipobroman | 1 | + | |